BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9675258)

  • 1. Activation and detoxication of aflatoxin B1.
    Guengerich FP; Johnson WW; Shimada T; Ueng YF; Yamazaki H; Langouët S
    Mutat Res; 1998 Jun; 402(1-2):121-8. PubMed ID: 9675258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in the metabolism of aflatoxin B1 and relevance to risk of human liver cancer.
    Guengerich FP; Johnson WW; Ueng YF; Yamazaki H; Shimada T
    Environ Health Perspect; 1996 May; 104 Suppl 3(Suppl 3):557-62. PubMed ID: 8781383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biotransformation of aflatoxin B1 in human lung.
    Donnelly PJ; Stewart RK; Ali SL; Conlan AA; Reid KR; Petsikas D; Massey TE
    Carcinogenesis; 1996 Nov; 17(11):2487-94. PubMed ID: 8968067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase-catalyzed conjugation of bioactivated aflatoxin B1 in rabbit lung and liver.
    Stewart RK; Serabjit-Singh CJ; Massey TE
    Toxicol Appl Pharmacol; 1996 Oct; 140(2):499-507. PubMed ID: 8887467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1.
    Kamdem LK; Meineke I; Gödtel-Armbrust U; Brockmöller J; Wojnowski L
    Chem Res Toxicol; 2006 Apr; 19(4):577-86. PubMed ID: 16608170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual differences in response to chemoprotection against aflatoxin-induced hepatocarcinogenesis: implications for human biotransformation enzyme polymorphisms.
    Eaton DL; Bammler TK; Kelly EJ
    Adv Exp Med Biol; 2001; 500():559-76. PubMed ID: 11764998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aflatoxin B1 8,9-epoxide hydrolysis in the presence of rat and human epoxide hydrolase.
    Johnson WW; Yamazaki H; Shimada T; Ueng YF; Guengerich FP
    Chem Res Toxicol; 1997 Jun; 10(6):672-6. PubMed ID: 9208174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of highly reactive aflatoxin B1 exo-8,9-epoxide catalyzed by rat and human glutathione transferases: estimation of kinetic parameters.
    Johnson WW; Ueng YF; Widersten M; Mannervik B; Hayes JD; Sherratt PJ; Ketterer B; Guengerich FP
    Biochemistry; 1997 Mar; 36(11):3056-60. PubMed ID: 9115980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative biotransformation of aflatoxin B1 in mammalian airway epithelium.
    Ball RW; Coulombe RA
    Carcinogenesis; 1991 Feb; 12(2):305-10. PubMed ID: 1899809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture.
    Langouët S; Coles B; Morel F; Becquemont L; Beaune P; Guengerich FP; Ketterer B; Guillouzo A
    Cancer Res; 1995 Dec; 55(23):5574-9. PubMed ID: 7585637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of aflatoxin B1 exo-8,9-epoxide with DNA: kinetic analysis of covalent binding and DNA-induced hydrolysis.
    Johnson WW; Guengerich FP
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6121-5. PubMed ID: 9177180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione conjugation of aflatoxin B1 exo- and endo-epoxides by rat and human glutathione S-transferases.
    Raney KD; Meyer DJ; Ketterer B; Harris TM; Guengerich FP
    Chem Res Toxicol; 1992; 5(4):470-8. PubMed ID: 1391613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin B
    Deng J; Zhao L; Zhang NY; Karrow NA; Krumm CS; Qi DS; Sun LH
    Mutat Res Rev Mutat Res; 2018; 778():79-89. PubMed ID: 30454686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The kinetics of aflatoxin B1 oxidation by human cDNA-expressed and human liver microsomal cytochromes P450 1A2 and 3A4.
    Gallagher EP; Kunze KL; Stapleton PL; Eaton DL
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):595-606. PubMed ID: 8975785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
    Scholl P; Musser SM; Kensler TW; Groopman JD
    Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of aflatoxin carcinogenesis.
    Eaton DL; Gallagher EP
    Annu Rev Pharmacol Toxicol; 1994; 34():135-72. PubMed ID: 8042848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of aflatoxin B1 lung tumorigenesis.
    Massey TE; Smith GB; Tam AS
    Exp Lung Res; 2000 Dec; 26(8):673-83. PubMed ID: 11195464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation of aflatoxin B1 by bacterial recombinant human cytochrome P450 enzymes.
    Ueng YF; Shimada T; Yamazaki H; Guengerich FP
    Chem Res Toxicol; 1995 Mar; 8(2):218-25. PubMed ID: 7766804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro metabolism of aflatoxin B1 by normal and tumorous liver tissue from Thailand.
    Kirby GM; Wolf CR; Neal GE; Judah DJ; Henderson CJ; Srivatanakul P; Wild CP
    Carcinogenesis; 1993 Dec; 14(12):2613-20. PubMed ID: 8269634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.